Literature DB >> 18073111

Transformation efficiency of RasQ61 mutants linked to structural features of the switch regions in the presence of Raf.

Greg Buhrman1, Glenna Wink, Carla Mattos.   

Abstract

Transformation efficiencies of Ras mutants at residue 61 range over three orders of magnitude, but the in vitro GTPase activity decreases 10-fold for all mutants. We show that Raf impairs the GTPase activity of RasQ61L, suggesting that the Ras/Raf complex differentially modulates transformation. Our crystal structures show that, in transforming mutants, switch II takes part in a network of hydrophobic interactions burying the nucleotide and precatalytic water molecule. Our results suggest that Y32 and a water molecule bridging it to the gamma-phosphate in the wild-type structure play a role in GTP hydrolysis in lieu of the Arg finger in the absence of GAP. The bridging water molecule is absent in the transforming mutants, contributing to the burying of the nucleotide. We propose a mechanism for intrinsic hydrolysis in Raf-bound Ras and elucidate structural features in the Q61 mutants that correlate with their potency to transform cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18073111      PMCID: PMC2273997          DOI: 10.1016/j.str.2007.10.011

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  36 in total

1.  Structural view of the Ran-Importin beta interaction at 2.3 A resolution.

Authors:  I R Vetter; A Arndt; U Kutay; D Görlich; A Wittinghofer
Journal:  Cell       Date:  1999-05-28       Impact factor: 41.582

Review 2.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 3.  Substrate assisted catalysis -- application to G proteins.

Authors:  M Kosloff; Z Selinger
Journal:  Trends Biochem Sci       Date:  2001-03       Impact factor: 13.807

4.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

5.  Crystallographic evidence for substrate-assisted GTP hydrolysis by a small GTP binding protein.

Authors:  Sebastiano Pasqualato; Jacqueline Cherfils
Journal:  Structure       Date:  2005-04       Impact factor: 5.006

6.  Structure of a transient intermediate for GTP hydrolysis by ras.

Authors:  Bradley Ford; Viktor Hornak; Holly Kleinman; Nicolas Nassar
Journal:  Structure       Date:  2006-03       Impact factor: 5.006

7.  Crystallography & NMR system: A new software suite for macromolecular structure determination.

Authors:  A T Brünger; P D Adams; G M Clore; W L DeLano; P Gros; R W Grosse-Kunstleve; J S Jiang; J Kuszewski; M Nilges; N S Pannu; R J Read; L M Rice; T Simonson; G L Warren
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1998-09-01

8.  Vibrational structure of GDP and GTP bound to RAS: an isotope-edited FTIR study.

Authors:  H Cheng; S Sukal; H Deng; T S Leyh; R Callender
Journal:  Biochemistry       Date:  2001-04-03       Impact factor: 3.162

9.  The pre-hydrolysis state of p21(ras) in complex with GTP: new insights into the role of water molecules in the GTP hydrolysis reaction of ras-like proteins.

Authors:  A J Scheidig; C Burmester; R S Goody
Journal:  Structure       Date:  1999-11-15       Impact factor: 5.006

Review 10.  G protein mechanisms: insights from structural analysis.

Authors:  S R Sprang
Journal:  Annu Rev Biochem       Date:  1997       Impact factor: 23.643

View more
  44 in total

Review 1.  Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view.

Authors:  Shaoyong Lu; Hyunbum Jang; Shuo Gu; Jian Zhang; Ruth Nussinov
Journal:  Chem Soc Rev       Date:  2016-07-11       Impact factor: 54.564

2.  The small GTPases K-Ras, N-Ras, and H-Ras have distinct biochemical properties determined by allosteric effects.

Authors:  Christian W Johnson; Derion Reid; Jillian A Parker; Shores Salter; Ryan Knihtila; Petr Kuzmic; Carla Mattos
Journal:  J Biol Chem       Date:  2017-06-19       Impact factor: 5.157

3.  Allosteric modulation of Ras-GTP is linked to signal transduction through RAF kinase.

Authors:  Greg Buhrman; V S Senthil Kumar; Murat Cirit; Jason M Haugh; Carla Mattos
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

4.  Allosteric modulation of Ras positions Q61 for a direct role in catalysis.

Authors:  Greg Buhrman; Genevieve Holzapfel; Susan Fetics; Carla Mattos
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-01       Impact factor: 11.205

Review 5.  Biology, pathology, and therapeutic targeting of RAS.

Authors:  J Matthew Rhett; Imran Khan; John P O'Bryan
Journal:  Adv Cancer Res       Date:  2020-07-09       Impact factor: 6.242

6.  IQGAP-related protein IqgC suppresses Ras signaling during large-scale endocytosis.

Authors:  Maja Marinović; Lucija Mijanović; Marko Šoštar; Matej Vizovišek; Alexander Junemann; Marko Fonović; Boris Turk; Igor Weber; Jan Faix; Vedrana Filić
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-08       Impact factor: 11.205

7.  Analysis of binding site hot spots on the surface of Ras GTPase.

Authors:  Greg Buhrman; Casey O'Connor; Brandon Zerbe; Bradley M Kearney; Raeanne Napoleon; Elizaveta A Kovrigina; Sandor Vajda; Dima Kozakov; Evgenii L Kovrigin; Carla Mattos
Journal:  J Mol Biol       Date:  2011-09-16       Impact factor: 5.469

8.  Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma.

Authors:  Christin E Burd; Wenjin Liu; Minh V Huynh; Meriam A Waqas; James E Gillahan; Kelly S Clark; Kailing Fu; Brit L Martin; William R Jeck; George P Souroullas; David B Darr; Daniel C Zedek; Michael J Miley; Bruce C Baguley; Sharon L Campbell; Norman E Sharpless
Journal:  Cancer Discov       Date:  2014-09-24       Impact factor: 39.397

9.  Mutations in specific codons of the KRAS oncogene are associated with variable resistance to neoadjuvant chemoradiation therapy in patients with rectal adenocarcinoma.

Authors:  Marjun P Duldulao; Wendy Lee; Rebecca A Nelson; Wenyan Li; Zhenbin Chen; Joseph Kim; Julio Garcia-Aguilar
Journal:  Ann Surg Oncol       Date:  2013-03-02       Impact factor: 5.344

10.  KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer.

Authors:  F Loupakis; A Ruzzo; C Cremolini; B Vincenzi; L Salvatore; D Santini; G Masi; I Stasi; E Canestrari; E Rulli; I Floriani; K Bencardino; N Galluccio; V Catalano; G Tonini; M Magnani; G Fontanini; F Basolo; A Falcone; F Graziano
Journal:  Br J Cancer       Date:  2009-07-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.